Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BYMedical sciences (Basel, Switzerland)

From cN2 to ypN0: Nodal Downstaging After Neoadjuvant Treatment in Breast Cancer—A Retrospective Cohort Study from a Tertiary Cancer Center

1 more authors
10 affiliations
  1. 1Department of Oncological Surgery, , 400012 Cluj-Napoca, Romania
  2. 2Faculty of Medicine, , 400012 Cluj-Napoca, Romania
  3. 3Department of Otorhinolaryngology, , 400012 Cluj-Napoca, Romania
  4. 4Department of Oncology, “Prof. Dr. Ion Chiricuță” Institute of Oncology, 400015 Cluj-Napoca, Romania
  5. 5Department of Radiology, , 400012 Cluj-Napoca, Romania
  6. 6Department of Surgery, Regina Maria Ponderas Academic Hospital, 014142 Bucharest, Romania
  7. 7Regina Maria Hospital, 500091 Brașov, Romania
  8. 8Ovidius Clinical Hospital, 905900 Constanța, Romania
  9. 9, 050474 Bucharest, Romania
  10. 10Department of Plastic Surgery, “Prof. Dr. Ion Chiricuță” Institute of Oncology, 400015 Cluj-Napoca, Romania

Related

  1. Predictive and Prognostic Value of Androgen Receptor Expression Across All Molecular Subtypes in Patients with Breast Cancer Who Received Neoadjuvant-Treatment: Single-Center Retrospective Analysis.
    Harun Muğlu, Vedat Buğra Erol, Hakan Özçelik +14
    Breast cancer (Dove Medical Press)Peer-reviewedCC BY-NCFull textOncologyEurope PMC
  2. Pretreatment Body Composition and Its Association with Pathologic Complete Response and Survival in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Retrospective Cohort Study
    Erhan Tükel, Süleyman Özkan Aksoy, Ali İbrahim Sevinç +9
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Impact of neoadjuvant chemotherapy on local breast microbiota and macrophages in ER-positive breast cancer with links to treatment response
    Sabine Dieleman, Carlijn Bruggeling, Phuc Dat Le +14
    NPJ Breast CancerPeer-reviewedCC BY 4.0Full text1 citedOncologyPMC
  4. Residual DCIS Versus No Residual Breast Tumor After Neoadjuvant Chemotherapy in ypN0 Breast Cancer: A Retrospective Clinical, MRI, and Survival Comparison
    Özlem Mermut, Berrin Yalçın, Rıza Umar Gürsu +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  5. Pre-treatment prediction of response to neoadjuvant chemotherapy in breast cancer patients using a nomogram based on findings from cone-beam breast computed tomography.
    Yu-Jiao Zhang, Zhu-Ming Liang, Xiang-Yang Huang +4
    BMC cancerPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
BibTeX
@article{gata2026from,
  title = {{From cN2 to ypN0: Nodal Downstaging After Neoadjuvant Treatment in Breast Cancer—A Retrospective Cohort Study from a Tertiary Cancer Center}},
  author = {Vlad Alexandru Gâta and Radu Alexandru Ilieș and Ana Maria Mureșan-Bădescu and Teodor Marian Vancea and Anda Gâta and Nicoleta Zenovia Antone and Roxana Pintican and Simona Ioana Filip and Gerald Gheorghe Filip and Eugeniu Darii and Iyad Shahin and Răzvan-Valentin Scăunașu and Maximilian Vlad Muntean},
  journal = {Medical sciences (Basel, Switzerland)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13706925},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - From cN2 to ypN0: Nodal Downstaging After Neoadjuvant Treatment in Breast Cancer—A Retrospective Cohort Study from a Tertiary Cancer Center
AU  - Vlad Alexandru Gâta
AU  - Radu Alexandru Ilieș
AU  - Ana Maria Mureșan-Bădescu
AU  - Teodor Marian Vancea
AU  - Anda Gâta
AU  - Nicoleta Zenovia Antone
AU  - Roxana Pintican
AU  - Simona Ioana Filip
AU  - Gerald Gheorghe Filip
AU  - Eugeniu Darii
AU  - Iyad Shahin
AU  - Răzvan-Valentin Scăunașu
AU  - Maximilian Vlad Muntean
PY  - 2026
DA  - 2026/10/01
JO  - Medical sciences (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13706925
SN  - 2076-3271
ER  -